Jack Khattar, President & CEO, Director at Supernus Pharmaceuticals, holds 2.22M shares in Supernus Pharmaceuticals (Ticker: SUPN), holds 73.50K shares in Cognition Therapeutics (Ticker: CGTX), holds 0.00 shares in scPharmaceuticals (Ticker: SCPH).
What is the percentage of profitable transactions made by Jack Khattar?
The percentage of profitable transactions made by Jack Khattar is 75%.
What is the average return per transaction made by Jack Khattar?
The average return per transaction made by Jack Khattar is 5.00%.
What stocks does Jack Khattar hold?
Jack Khattar holds: SUPN, TSRO, SCPH, CGTX stocks.
What was Jack Khattar’s latest transaction?
Jack Khattar latest transaction was an Uninformative Buy of $801.33K.
What was Jack Khattar's most profitable transaction?
Jack Khattar’s most profitable transaction was an Informative Buy of SCPH stock on December 6, 2021. The return on the trade was 62.60%.
What is Jack Khattar's role in Supernus Pharmaceuticals?
Jack Khattar's role in Supernus Pharmaceuticals is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.